The Aussie biotech giant will bring the first gene therapy for haemophilia B to market in the US, but the one-off treatment comes with a hefty price tag.
Business / Companies
Brisbane Times – Business
The Aussie biotech giant will bring the first gene therapy for haemophilia B to market in the US, but the one-off treatment comes with a hefty price tag.
Business / Companies
Brisbane Times – Business